BioFirst Overview
- Founded
- 2008

- Status
- Acquired/Merged
- Employees
- 360

- Latest Deal Type
- M&A
- Latest Deal Amount
- $14.2M

BioFirst General Information
Description
Developer of plant proteases products intended to substitute chemicals products. The company produces and markets natural technologies and products in agriculture, para pharmaceuticals, agri-foodstuffs, cosmetics, and health care and are environmentally friendly and sustainable alternatives to existing chemical products, enabling customers to get products that are safe for them as well as the environment.
Contact Information
- Drève Richelle 161 B4
- 1410 Waterloo
- Belgium
BioFirst Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
2. Merger/Acquisition | 22-Nov-2011 | $14.2M | 000.00 | Completed | Generating Revenue | |
1. Early Stage VC | Completed | Startup |
BioFirst Signals
Growth Rate

Growth

Size Multiple


Key Data Points
Twitter Followers
5.5k

Similarweb Unique Visitors
15.0K

Majestic Referring Domains
314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.
Request a free trialBioFirst Former Investors (2)
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|---|---|---|---|---|
Compagnie du Bois Sauvage | Corporation | Minority | 000 0000 | 000000 0 | |
Florinvest | Corporate Venture Capital | Minority | 000 0000 | 000000 0 |